Related Experiment Video
Updated: Jan 4, 2026
19:15
Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
87.4K
Neonatal pharmacology and clinical implications
Antonio Ruggiero1, Anna Ariano1, Silvia Triarico1
1Pediatric Oncology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Drugs in Context
|November 7, 2019
Summary
Neonatal drug dosing requires careful adjustment due to immature organ systems affecting drug absorption, distribution, metabolism, and excretion (ADME). Understanding these physiological changes is key for safe and effective neonatal pharmacotherapy.
Area of Science:
- Neonatal pharmacology
- Clinical pharmacy
- Pediatric drug development
Background:
- Neonates exhibit physiological immaturity in organs, systems, and metabolic pathways.
- This immaturity significantly impacts drug pharmacokinetics and pharmacodynamics.
- Drug dosage requires continuous amendment due to weight gain and maturing elimination pathways.
Purpose of the Study:
- To analyze the primary pharmacokinetic aspects of drug disposition in neonates.
- To describe the physiological basis for altered drug dosing in the neonatal period.
- To provide insights for optimizing neonatal pharmacotherapy.
Main Methods:
- Review of physiological changes affecting drug pharmacokinetics in neonates.
- Analysis of absorption, distribution, metabolism, and excretion (ADME) during the neonatal period.
- Synthesis of current knowledge on neonatal drug disposition.
Main Results:
- Neonatal physiological immaturity alters drug absorption, distribution, metabolism, and excretion.
- Pharmacokinetic parameters in neonates differ significantly from older populations.
- Progressive maturation of organs and pathways necessitates dynamic dosage adjustments.
Conclusions:
- Understanding neonatal pharmacokinetics is crucial for safe and effective drug administration.
- Dosage regimens must account for developmental changes in neonates.
- Further research into neonatal drug disposition can improve therapeutic outcomes.
Related Concept Videos
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
222
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
222
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
160
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
160
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
181
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
181
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
209
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
209
01:21Factors Affecting Drug Response: Overview
2.8K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.8K
01:19Nonlinear Pharmacokinetics: Overview
1000
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
1000